Formula30A cannabinoids are created using full-spectrum hemp extract. In addition to key components such as CBD or CBG, there are over 100 other naturally occurring compounds present in our products, including trace amounts of THC (less than 0.3% by dry weight, as determined by US law). Just like the consumption of poppy seeds may lead to a positive drug test for opioids, the consumption of certain hemp products may lead to a positive drug test for THC.
That is why Formula30A advises patients to purchase their CBD from a licensed Medical Provider who can provide you and your employer with the necessary paperwork verifying Formula30A products contain less than the legal limit of 0.3 percent THC. Our Medical Advisory board recommends that you reach out to your Human Resources department or your employer with a letter from your provider and a copy of the Certificate of Analysis of Formula30A before consuming any cannabis-derived product. Once you have your approval, then you can enjoy the benefits of Formula30A without the risk.
Employers commonly use standard urine tests to identify illicit substances in the urine. As most of these types of tests are geared towards identifying THC, rather than CBD or other cannabinoids, trace amounts of THC in legal full spectrum cannabinoid products may register as a failed drug test. More accurate tests, such as blood tests that can measure THC from hemp versus THC from marijuana, can help to prevent false positives where available.
If you are consuming any cannabis product that claims to be THC-free or Isolate, it is strongly recommended that you consult with your physician. According to a 2020 study performed by the FDA, 45% of CBD products tested contained the amount of CBD advertised (within ±20%). Even more worrying, 49% of products test had THC levels that exceeded the legal limit for hemp extracts. We recommend that you always ask for a certificate of analysis and confer with your medical provider before consuming any cannabinoid product.